Cargando…
The start of chemotherapy until the end of radiotherapy in patients with limited-stage small cell lung cancer
BACKGROUND/AIMS: Chemotherapy combined with radiation therapy is the standard treatment for limited stage small cell lung cancer (LS-SCLC). Although numerous studies indicate that the overall duration of chemoradiotherapy is the most relevant predictor of outcome, the optimal chemotherapy and radiat...
Autores principales: | Lee, Kyoung Ju, Lee, Eun Joo, Hur, Gyu Young, Lee, Sang Yeub, Kim, Je Hyeong, Shin, Chol, Shim, Jae Jeong, In, Kwang Ho, Kang, Kyung Ho, Yoo, Se Hwa, Lee, Sung Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712153/ https://www.ncbi.nlm.nih.gov/pubmed/23864803 http://dx.doi.org/10.3904/kjim.2013.28.4.449 |
Ejemplares similares
-
Relationships of Coagulation Factor XIII Activity with Cell-Type and Stage of Non-Small Cell Lung Cancer
por: Lee, Seung Heon, et al.
Publicado: (2013) -
A Case of Paraneoplastic Limbic Encephalitis Associated with Small Cell Lung Cancer
por: Ryu, Ja Young, et al.
Publicado: (2012) -
Effects of Transglutaminase 2 Inhibition on Ventilator-Induced Lung Injury
por: Suh, In Bum, et al.
Publicado: (2014) -
A Case of IgG4-Related Disease Presenting as Massive Pleural Effusion and Thrombophlebitis
por: Choi, Jong Hyun, et al.
Publicado: (2014) -
Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
por: Lee, Seung Hyeun, et al.
Publicado: (2017)